Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Colorectal Neoplasms × zimberelimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumor, Unspecified, Adult 1 Prostatic Neoplasms, Castration-Resistant 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Advanced Solid Tumors 1

Interventions

Fluorouracil 210 Leucovorin 184 Oxaliplatin 175 Irinotecan 168 Bevacizumab 158 Capecitabine 120 Cetuximab 108 Panitumumab 56 Folfox protocol 55 regorafenib 43 pembrolizumab 36 IFL protocol 36 Colonoscopy 36 Radiotherapy 27 Nivolumab 27 Drug Therapy 24 Gemcitabine 21 Blood Specimen Collection 20 trifluridine tipiracil drug combination 19 Chemotherapy, Adjuvant 19 Surveys and Questionnaires 15 Neoadjuvant Therapy 15 durvalumab 14 Celecoxib 14 Surgical Procedures, Operative 13 Erlotinib Hydrochloride 13 Cyclophosphamide 13 Cisplatin 12 tremelimumab 11 XELOX 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04660812 2025-10-20

ARC-9

Arcus Biosciences, Inc.

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡